Heartflow Inc (HTFL): Rega marang dodolan

Heartflow Inc is implementing AI for non-invasive blood flow diagnostics based on CT scans, expanding insurance coverage. The price-to-sales ratio clearly demonstrates market expectations, where 24.50 captures the current value of the indicator. Leading data scientists working with unique datasets are building the company's technology stack. Management is currently focusing on scaling commercial processes to validate the clinical value of its digital platforms.

HTFL heartflow.com: Kapitalisasi marang pendapatan ing interval 09.08.2025 - 13.11.2026

Rincian metrik lan analitis perusahaan HeartFlow Corp (HTFL)

- rega saiki lan proyeksi nilai saham:

Bagan rega HeartFlow, Inc.|HTFL - Bagan rega target

- data kapitalisasi bursa:

Nilai pasar HeartFlow Corp|HTFL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Akuntansi saben Saham HeartFlow|HTFL - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku heartflow.com|HTFL - Total Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Koefisien Total Utang marang Modal Heartflow Inc|HTFL - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal HeartFlow Medical|HTFL - Gunggung utang perusahaan|Utang marang nilai buku HeartFlow Corp|HTFL - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan HeartFlow|Rasio likuiditas perantara heartflow.com

- data bathi bisnis lan rasio investasi:

HTFL - Bathi resik|Bathi forward Heartflow Inc|HTFL - Rasio rega marang bathi|Rega marang bathi mangsa ngarep HeartFlow|HTFL - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan HeartFlow Corp|HTFL - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan HeartFlow|HTFL - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan heartflow.com|HTFL - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Heartflow Inc

- indikator pendapatan dodolan lan penghasilan bisnis:

HTFL - Dodolan perusahaan|Prakiraan volume pendapatan perusahaan HeartFlow Corp|HTFL - Multiplikator P/S|Rega forward marang dodolan HeartFlow Corp

Analisis umum perusahaan:HTFL (heartflow.com)

For Heartflow Inc (HTFL), which develops high-tech cardiology software with no direct environmental impact, revenue serves as the key driver of capitalization. By analyzing the price-to-sales ratio, an investor compares the market share price with actual business earnings to determine the asset's degree of overvaluation and distinguish genuine growth from speculative momentum, based on the price action reflected in this chart.

Perusahaan pesaing

Rasio rega marang pendapatan REGN (regeneron.com)|Rasio rega marang pendapatan iRhythm IRTC|Lantheus Holdings (LNTH) - Rega marang dodolan|MLYS: Kapitalisasi marang pendapatan|Kestra Medical Corp (KMTS) - Kapitalisasi marang pendapatan|ESPR (Esperion Therapeutics) - Kapitalisasi marang pendapatan|amarincorp.com - Rasio kapitalisasi pasar marang pendapatan|AVR (Anteris) - Multiplikator P/S|Tenaya Therapeutics Inc (TNYA) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan CVRx, Inc (CVRX)|Milestone Pharmaceuticals Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S CRDL (Cardiol Therapeutics Inc.)|BEAT - Kapitalisasi marang pendapatan|Tenax Therapeutics, Inc. - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ADGM (Adagio Medical Holdings, Inc.)|BCDA (BioCardia, Inc) - Kapitalisasi marang pendapatan|VTAK: Kapitalisasi marang volume dodolan|ABIO (ARCA Biopharma Inc) - Multiplikator P/S|Acasti - Rasio rega marang dodolan|Rasio rega marang pendapatan Aerovate Therapeutics, Inc. (AVTE)|Rasio rega marang pendapatan VERV (vervetx.com)|Multiplikator P/S WINT (Windtree Therapeutics, Inc.)